Oculopharyngeal muscular dystrophy (OPMD) is an evidence against a strong founder effect in the UK population. There was a weak association between repeat autosomal dominant disorder of late onset that commonly length and age of disease onset. Patients with longer presents with ptosis and dysphagia. The genetic basis of repeat lengths, such as (GCG) 13 , developed severe limb the condition has been identified recently as a stable weakness early in the disease. We were unable to detect trinucleotide repeat expansion in exon 1 of the poly(A) the (GCG) 7 polymorphism in over 200 normal controls, binding protein 2 gene (PABP2), in which (GCG) 6 is the suggesting that the frequency of this expansion is lower normal repeat length. The prevalence of OPMD is greatest than that found in the French-Canadian population. One in patients of French-Canadian origin. It is not clear if family was negative for the expansion. Affected members expansion repeat length is a reliable test in other presented with the classical features of OPMD, namely populations. In this study, we analysed the phenotypic ptosis, dysphagia and cytoplasmic inclusions on muscle and genotypic characteristics of 31 patients with OPMD biopsy, although with some atypical features, such as in the UK. Ptosis was the first reported symptom in twoearly age of onset, high serum levels of creatine kinase and thirds of the patients, and half of the subjects studied a profound ophthalmoplegia. This family is an example of had evidence of ophthalmoplegia. All but one family had a GCG expansion-negative oculopharyngeal syndrome a pathological expansion in the PABP2 gene, ranging from requiring further genetic investigation. We conclude that (GCG) 8 to (GCG) 13 . In contrast to the French-Canadian PABP2 analysis is a reliable non-invasive diagnostic test for OPMD in the UK population. population, (GCG) 10 was almost as common as (GCG) 9 ,
Introduction
Oculopharyngeal muscular dystrophy (OPMD) is a late-onset, demonstrated filamentous nuclear inclusions in a minority of fibres that are not seen in other inherited or acquired muscle dominantly inherited disorder characterized by progressive ptosis, dysphagia and proximal limb weakness. It was first diseases (Tomé and Fardeau, 1980) . Until recently, the diagnosis of OPMD was made on the described in 1915 (Taylor, 1915) , when it was attributed to a progressive cranial neuropathy. However, in 1962, Victor basis of clinical features, muscle histology and a positive family history. However, in 1998, Brais and colleagues and colleagues clearly demonstrated that the primary pathology was myopathic and that it was inherited in an identified a stable trinucleotide repeat expansion at the N-terminus of a poly(A) binding protein gene (PABP2) on autosomal dominant manner (Victor et al., 1962) . Muscle histology in affected individuals typically reveals abnormal chromosome 14 in 144 affected families (Brais et al., 1998) , thereby allowing genetic diagnosis in affected individuals. variability in fibre size, an increase in endomysial fibrosis, and cytoplasmic basophilic rimmed vacuoles similar to those
The identification of trinucleotide repeat expansions in specific genes has become a common theme in inherited seen in inclusion body myositis (Coquet et al., 1990) . Ultrastructural studies on muscle in OPMD have neurological diseases (Rosenberg, 1996) . However, the PABP2 repeat expansion in OPMD is unusual in a number of respects. First, the expansion is modest, increasing from (GCG) 6 in normal individuals to only (GCG) [8] [9] [10] [11] [12] [13] in affected individuals, and the repeat length is relatively stable during meiosis (Brais et al., 1998) . Furthermore, in the rare autosomal recessive form of OPMD first reported by Fried and colleagues (Fried et al., 1975) , affected individuals are homozygous for the (GCG) 7 repeat, an allele that is found in 2% of the French-Canadian population. Brais and colleagues also speculated that the (GCG) 7 polymorphism may have disease-modifying effects, because a compound heterozygote with (GCG) 7 (GCG) 9 displayed a more severe disease phenotype than a sibling with (GCG) 6 (GCG) 9 . Although OPMD has a world-wide distribution, its prevalence is highest in French-Canadian kindreds, and most of the families included in the study of Brais and colleagues (Brais et al., 1998) were drawn from this population. Here we report the clinical and genetic characteristics of OPMD in 31 individuals (23 families) from the south of England. had confirmed the diagnosis. Details of other positive patients were obtained confidentially from the referring consultant.
5Ј-ACAAGATGGCGCCGCCGCCCCGGC-3Ј. The reverse Because of the insidious nature of the condition, it was often primer was labelled fluorescently (HEX) at the 5Ј end. only possible to approximate the date of the earliest symptom.
Thermocycling conditions were 94°C for 20 min followed A control population of 201 anonymous DNA samples from by 35 cycles of 94°C for 1 min, 64°C for 1 min and 72°C individuals with no known family history of OPMD was also for 1 min, and a final step of 72°C for 7 min. There is analysed for an expansion of the (GCG) repeat. Ethical significant preferential amplification of the smaller allele, approval for the study was obtained from the Salisbury which makes detection of expanded alleles more difficult Research Ethics Committee and the Southampton and South (Fig. 1) . We modified the thermocycling parameters of Brais West Hampshire Joint Research Ethics Committee. and colleagues (Brais et al., 1998) in order to minimize this effect. The PCR products were separated according to size by electrophoresis through 4% polyacrylamide on an ABI 377 automated DNA analyser (PE Biosystems, Warrington, UK).
Genetic analysis
Analysis of the PABP2 gene for expansion of the (GCG) n Fragment size analysis was carried out using the ABI software packages Genescan version 2.1 and Genotyper version 2.0 repeat sequence was performed essentially as described by Brais and colleagues (Brais et al., 1998) . PCR (polymerase (PE Biosystems).
Haplotype analysis was performed on all affected chain reaction) amplification was carried out in a volume of 20 µl containing 100 ng of genomic DNA (from peripheral individuals using the chromosome 14-specific markers D14S1041, D14S990 and D14S283 from the region of interest blood), 0.5 U Taq polymerase (Hotstar Taq; Qiagen, Crawley, UK), using the manufacturer's reaction buffer supplemented (Grewal et al., 1998) . PCR amplification was carried out in a reaction volume of 20 µl that contained 100 ng DNA, with an additional 0.5 mM MgCl 2 to a final concentration of 2 mM, 20% Q solution (Qiagen), 100 nM dTTP, dCTP and 0.1 U Taq polymerase, dCTP, dTTP, dATP and dGTP, each at 200 nM, and each primer at 0.5 µM. One primer of each dATP, 50 nM dGTP, 50 nM deaza-dGTP and each primer at 0.5 µM. Primer sequences were as follows: PABPF (forward), pair was labelled fluorescently. Thermocycling conditions were 20 min at 94°C followed by 32 cycles of 94°C for 30 s, 5Ј-CGCAGTGCCCCGCCTTAGA-3Ј; PABPR (reverse), HEX As in the report of Brais and colleagues (Brais et al., 1998) , (GCG) 9 was the most common repeat length (40% of families), although (GCG) 10 was detected in one-third of families (36%). There appeared to be little difference in the age at disease onset between these two groups of patients. No homozygotes for the (GCG) 7 polymorphism or longer repeats were detected. Four pairs of siblings were analysed, and the expansion size was the same for each sibling in all four cases. Analysis of 201 control individuals with no known family history of OPMD showed all to have two (GCG) 6 alleles.
One family was found to be negative for the mutation. Members of this family had an atypical form of OPMD characterized by early symptom onset in the second or third decade, profound ophthalmoplegia and elevated serum levels of creatine kinase (324-1076 IU; normal range 25-170). Muscle biopsy revealed basophilic rimmed vacuoles with no red fibres) and 3243 MELAS (mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes) mutations was negative. In the two affected family members, 60°C for 30 s and 72°C for 2 min. PCR products were analysed on an ABI 377 DNA analyser.
the remainder of the PABP2 gene was analysed by singlestrand conformation polymorphism for mutations other than the (GCG) repeat amplification. No other mutation was identified, although this technique does not identify all
Results
Clinical and genetic information was obtained from 31 potential mutations. It is also possible that a large expansion of the PABP2 gene would not be detected by conventional affected individuals from 23 families. The presumptive diagnosis of OPMD was based on clinical features, family PCR because of preferential amplification of the smaller allele. However, analysis by Southern blotting of the PCR history and, in some cases, typical histological changes on muscle biopsy. Age at disease onset ranged from 17 to products and hybridization with a chemiluminescent (GCG) oligomer probe did not reveal an unusually large (GCG) 70 years, with a mean of 51 years; 61% of the individuals were female. All of the patients were Caucasian and were expansion. Linkage analysis carried out on the five available members of this family did not exclude linkage to resident in the south of England. In two-thirds of the patients, ptosis was the first symptom noted by the patient. Half of chromosome 14q, but too few meioses were analysed to provide positive evidence of linkage to chromosome 14q the patients had some limitation of extra-ocular movements, which were graded moderate or severe. At the time of the (data not shown).
Haplotype analysis of all those with a GCG expansion study, 19 of the subjects had undergone some form of corrective surgery for their ptosis and nine had required either revealed at least four different haplotypes segregating with the GCG expansion (data not shown). The parents of the oesophageal dilatation or insertion of a feeding percutaneous gastrostomy tube to assist nutrition. Of the three patients patients were not available for analysis, so it was not possible to assign a specific haplotype to the expanded allele. However, who presented with limb weakness, two had large expansions totalling 13 repeats. Disease onset in a sibling pair who were the spread of allele sizes allowed us to discern at least four different haplotypes segregating with the expansion. compound heterozygotes for PABP2 [(GCG) 7 (GCG) 8 ] (Fig. 2) was significantly earlier than for the unrelated subject with (GCG) 6 (GCG) 8 .
Pathological (GCG) repeat expansions in the PABP2 gene
Discussion
All of our patients with genetically proven classical OPMD were identified in all families but one. Plotting repeat length against age at symptom onset demonstrated a trend towards displayed the typical features of ptosis and dysphagia, though proximal limb weakness was a variable finding. Although earlier onset only in those subjects with longer repeats. Taking an extreme example, the sibling pair with 13 repeats others have reported that dysphagia is rarely present at presentation (Murphy and Drachman, 1968) , it was the first (expansion of seven triplets) presented in their forties, whereas the patient with the (GCG) 8 mutation (expansion of two reported symptom in 23% of the patients in our series. In the majority of patients (61%), ptosis was severe enough to triplets) was asymptomatic until the age of 70 years (Fig. 2) . warrant corrective surgery, whereas oesophageal dilatation We have shown that longer repeat expansions tend to result in earlier disease onset in OPMD, although this effect is or insertion of a percutaneous gastrostomy feeding tube was only required in 22%. It is also worthy of note that half of less striking than that seen with other trinucleotide repeat disorders. Such analyses are complicated by the insidious the patients were noted to have a moderate or severe restriction of ocular movement in at least one direction of nature of the condition, making accurate dating of disease onset difficult, though the small range of repeat lengths and gaze at the time of presentation. This sign is not often commented on, yet one of the three cases described in the the stability of the expansion is also likely to limit the range of disease severity. Thus, the predominance of the (GCG) 9 original paper of Victor and colleagues was noted to have a '. . . moderately severe impairment of ocular movement in and (GCG) 10 mutations is likely to contribute to the homogeneity of the disease phenotype. Our data also add all directions of gaze . . . ' (Victor et al., 1962) . Murphy and Drachman also recorded extra-ocular muscle weakness in a support to the observation that the polymorphism (GCG) 7 may have a disease-modifying effect, in that the compound proportion of subjects, although their data were incomplete (Murphy and Drachman, 1968) . Our data suggest that a heterozygote sibling pair presented much earlier than the patient with the (GCG) 6 (GCG) 8 phenotype, although the fact degree of external ophthalmoplegia is a relatively common finding in OPMD, at least in the UK population.
that they were not related makes it difficult to draw direct comparisons. It was reported recently that compound This study provides confirmation that the detection of expanded (GCG) repeat lengths in the PABP2 gene is an heterozygotes were relatively common in the Italian population (Mirabella et al., 2000) , yet these subjects did not appropriate diagnostic test for OPMD in a population of patients from the south of England. However, our results appear to have early-onset disease. Further data are required to clarify the role of (GCG) 7 in modifying the disease differ from those reported in previous studies in two respects. First, the spread of expansion repeat lengths was evenly phenotype.
One family presenting with the typical features of OPMD, distributed between (GCG) 9 and (GCG) 10 , both of which were detected in approximately one-third of the families namely ptosis, dysphagia and cytoplasmic inclusions on muscle histology, was found to be negative for the PABP2 involved in the study. In contrast, Brais and colleagues found that nearly 70% of their sample population, drawn from 15 repeat expansion. However, affected members of this family did display atypical features, such as early age of onset, countries, had nine repeats (Brais et al., 1998) . Although Brais and colleagues did not provide a breakdown correlating profound external ophthalmoplegia and high serum creatine kinase levels. The possibility that these patients had a country of origin with repeat length, they noted that the (GCG) 9 mutation was detected in all French-Canadian mitochondrial myopathy was considered, but was felt to be unlikely in view of the absence of cytochrome oxidasefamilies with OPMD, suggesting a strong founder effect in this population. A report of mutation analysis in three negative and ragged red fibres upon histological analysis and the absence of the common mitochondrial mutations. There Hispanic American families (Grewal et al., 1999) also demonstrated the predominance of the (GCG) 9 allele, are isolated case reports in the literature of patients presenting with progressive ptosis and dysphagia with variable additional although the numbers are too small to permit any comments on common origin.
features. Rose and colleagues described a Greek sibling pair with a progressive dystrophy presenting in adolescence that The distribution of repeat lengths in our population suggests that it is unlikely that there is a common founder. This led rapidly to respiratory failure (Rose et al., 1997) . Like our family, they had elevated serum creatine kinase levels and hypothesis was supported by the haplotype analysis of all of the positive subjects. At least four different haplotypes muscle biopsies showed dystrophic changes with basophilic rimmed vacuoles. Electron microscopy revealed filamentous were identified, indicating separate origins of the (GCG) expansions. This is likely to be an underestimate of the actual intranuclear inclusions similar to those that have been described previously in autosomal dominant and recessive number of distinct haplotypes, because in most cases parents were not available for analysis and the assignment of alleles OPMD (Schröder et al., 1995) . It is possible that these cases were a further example of autosomal recessive OPMD, to a specific chromosome was thus not possible. A similar, smaller study of expansion repeat lengths in OPMD in an though the results of mutation analysis have not been reported. There are two reports of a total of five families with an Italian population (Mirabella et al., 2000) also demonstrated a more diverse distribution of mutations than that reported autosomal dominant 'oculopharyngodistal myopathy' characterized by distal limb weakness in association with in the study of Brais and colleagues (Brais et al., 1998) , mirroring our findings in the UK. ocular and bulbar dysfunction (Satoyoshi and Kinoshita, 1977; Scrimgeour and Mastaglia, 1984) . Like the family The second unexpected finding concerned the (GCG) 7 polymorphism. This is reported to have a background reported here, these patients had a profound ophthalmoplegia, although proximal limb muscle strength was relatively frequency of 2% in the French-Canadian population. We failed to detect it in 201 normal individuals, suggesting that preserved. Muscle histology in all of these cases showed marked dystrophic changes but no basophilic rimmed the frequency in the UK population is smaller, perhaps Ͻ0.5%. 
